Certara Announces 2026 Certainty Event
CERTAINTY 2026: Explore AI-driven drug development and technological innovation at the leading biosimulation event for…
Certara2026 年 3 月 9 日
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…
Certara2026 年 2 月 26 日
The data fragmentation problem holding drug discovery back
Explore how fragmented data across the drug discovery DMTA cycle impedes progress, and discover how…
Certara2026 年 1 月 21 日
Safety First: Uncovering the Clinical Risks Inside Your Compound Screening Data
Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and…
Certara2026 年 1 月 13 日
Add Off-target Risk Profiling to Your Analyses
Certara's cheminformatics solution, D360, supports a key feature of Secondary Intelligence: a low-medium-high ranking of…
Certara2026 年 1 月 5 日
